APPLICATION
ANDA077120
TYPE
ANDA
ORIGINAL APPROVAL
2008-06-02
LATEST ACTION
2026-05-28
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
CARBIDOPA AND LEVODOPADiscontinued
CARBIDOPA 10MG, LEVODOPA 100MG · TABLET · ORAL
CARBIDOPA AND LEVODOPADiscontinued
CARBIDOPA 25MG, LEVODOPA 100MG · TABLET · ORAL
CARBIDOPA AND LEVODOPADiscontinued
CARBIDOPA 25MG, LEVODOPA 250MG · TABLET · ORAL
Approval history
2026-05-28Labeling · Supplement 9 · standardAP
2021-02-04Labeling · Supplement 7 · standardAP
2016-01-04Labeling · Supplement 4 · standardAP
2010-12-29Labeling · Supplement 3AP
2008-06-02OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.